Liao, Jun published the artcileEfficacy of vestibular rehabilitation training combined with medication in treatment of vestibular neuritis, Computed Properties of 54856-23-4, the publication is Sichuan Yixue (2017), 38(3), 332-334, database is CAplus.
Objective: To observe and evaluate the clin. effect of vestibular rehabilitation training combined with drug therapy in the treatment of vestibular neuritis. Methods: 30 cases of vestibular neuritis diagnosed during hospital stay between Sept. 2014 and Sept. 2015 in our department were included. 15 patients in exptl. group received vestibular rehabilitation training combined with drug therapy and 15 patients in control group only received drug therapy. Dizziness Handicap Inventory (DHI) scores on admission and 4 wk after onset of exptl. group and control group were compared. Results: Difference of DHI scores on admission between the two groups was not statistically significant (P>0.05). Both in two groups, differences of DHI scores before and after treatment were statistically significant (P<0.05). After 1 mo of treatment, comparing the differences of DHI scores in the two groups, the difference being statistically significant (P<0.05). Conclusion: Vestibular rehabilitation training combined with drug therapy can improve the prognosis of patients with vestibular neuritis.
Sichuan Yixue published new progress about 54856-23-4. 54856-23-4 belongs to pyridine-derivatives, auxiliary class Pyridine,Salt,Amine,Inhibitor,Inhibitor, name is N-Methyl-2-(pyridin-2-yl)ethan-1-amine dimethanesulfonate, and the molecular formula is C10H20N2O6S2, Computed Properties of 54856-23-4.
Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem